Financial Insights Inc. lessened its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 9.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,731 shares of the company’s stock after selling 277 shares during the quarter. Financial Insights Inc.’s holdings in Procter & Gamble were worth $473,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Acorn Creek Capital LLC grew its position in Procter & Gamble by 2.8% during the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after buying an additional 59 shares during the period. Alera Investment Advisors LLC grew its position in Procter & Gamble by 1.2% during the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after buying an additional 60 shares during the period. Hudson Value Partners LLC grew its position in Procter & Gamble by 4.1% during the second quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after buying an additional 60 shares during the period. Traveka Wealth LLC grew its position in Procter & Gamble by 1.7% during the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after buying an additional 60 shares during the period. Finally, Fiduciary Alliance LLC grew its position in Procter & Gamble by 2.8% during the second quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after buying an additional 61 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now directly owns 37,208 shares in the company, valued at $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at $6,325,360. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the sale, the chief executive officer now directly owns 13,721 shares in the company, valued at approximately $2,332,570. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 383,194 shares of company stock worth $65,140,718 over the last three months. Insiders own 0.18% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on Procter & Gamble
Procter & Gamble Price Performance
Shares of PG stock opened at $169.73 on Wednesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The firm’s 50-day moving average is $171.87 and its two-hundred day moving average is $167.43. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94. The company has a market capitalization of $400.59 billion, a PE ratio of 29.26, a price-to-earnings-growth ratio of 3.72 and a beta of 0.41.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same period last year, the business earned $1.83 earnings per share. The business’s revenue for the quarter was down .6% on a year-over-year basis. Analysts predict that The Procter & Gamble Company will post 6.98 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 69.48%.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- Transportation Stocks Investing
- Cisco: Why Analysts Are Targeting 35% Gains by Christmas
- What Are the FAANG Stocks and Are They Good Investments?
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- How to invest in marijuana stocks in 7 stepsĀ
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.